1. Home
  2. FTAIN vs SCLXW Comparison

FTAIN vs SCLXW Comparison

Compare FTAIN & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTAIN
  • SCLXW
  • Stock Information
  • Founded
  • FTAIN N/A
  • SCLXW N/A
  • Country
  • FTAIN United States
  • SCLXW United States
  • Employees
  • FTAIN 170
  • SCLXW N/A
  • Industry
  • FTAIN Misc Corporate Leasing Services
  • SCLXW Biotechnology: Pharmaceutical Preparations
  • Sector
  • FTAIN Industrials
  • SCLXW Health Care
  • Exchange
  • FTAIN Nasdaq
  • SCLXW Nasdaq
  • Market Cap
  • FTAIN N/A
  • SCLXW N/A
  • IPO Year
  • FTAIN N/A
  • SCLXW N/A
  • Fundamental
  • Price
  • FTAIN $25.28
  • SCLXW $0.18
  • Analyst Decision
  • FTAIN
  • SCLXW
  • Analyst Count
  • FTAIN 0
  • SCLXW 0
  • Target Price
  • FTAIN N/A
  • SCLXW N/A
  • AVG Volume (30 Days)
  • FTAIN N/A
  • SCLXW 4.0K
  • Earning Date
  • FTAIN N/A
  • SCLXW 03-07-2025
  • Dividend Yield
  • FTAIN N/A
  • SCLXW N/A
  • EPS Growth
  • FTAIN N/A
  • SCLXW N/A
  • EPS
  • FTAIN N/A
  • SCLXW N/A
  • Revenue
  • FTAIN N/A
  • SCLXW $55,152,000.00
  • Revenue This Year
  • FTAIN N/A
  • SCLXW N/A
  • Revenue Next Year
  • FTAIN N/A
  • SCLXW N/A
  • P/E Ratio
  • FTAIN N/A
  • SCLXW N/A
  • Revenue Growth
  • FTAIN N/A
  • SCLXW 22.02
  • 52 Week Low
  • FTAIN N/A
  • SCLXW $0.18
  • 52 Week High
  • FTAIN N/A
  • SCLXW $0.18
  • Technical
  • Relative Strength Index (RSI)
  • FTAIN 48.66
  • SCLXW N/A
  • Support Level
  • FTAIN $25.16
  • SCLXW N/A
  • Resistance Level
  • FTAIN $25.35
  • SCLXW N/A
  • Average True Range (ATR)
  • FTAIN 0.26
  • SCLXW 0.00
  • MACD
  • FTAIN 0.04
  • SCLXW 0.00
  • Stochastic Oscillator
  • FTAIN 66.67
  • SCLXW 0.00

About FTAIN FTAI Aviation Ltd. 8.25% Fixed - Rate Reset Series C Cumulative Perpetual Redeemable Preferred Shares

FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate strong and stable cash flows with the potential for earnings growth and asset appreciation.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: